Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | GSK3B | P49841 | 1/20 | 0.42 |
| ▸ | CACNA1C | Q13936 | 5/20 | 0.40 |
| ▸ | CACNA1F | O60840 | 2/20 | 0.40 |
| ▸ | CACNA1D | Q01668 | 2/20 | 0.40 |
| ▸ | CACNA1S | Q13698 | 2/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 4/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8795162 | 0.86 | SMN1; SMN2 (0.46) | SMN1; SMN2GSK3BCACNA1CCACNA1FCACNA1D | |
| SCHEMBL6270429 | 0.84 | AKR1B1 (0.40) | MAPTKMT2AALDH1A1MEN1CYP1A2 | |
| SCHEMBL8134324 | 0.83 | KMT2A (0.38) | SMN1; SMN2MAPTNPC1KMT2AALDH1A1 | |
| SCHEMBL8311296 | 0.82 | AKR1B1 (0.37) | MAPTKMT2AALDH1A1MEN1CYP3A4 | |
| SCHEMBL8313694 | 0.82 | ALPG (0.41) | SMN1; SMN2MAPTNPC1KMT2AALDH1A1 | |
| SCHEMBL6269237 | 0.82 | LMNA (0.40) | SMN1; SMN2ADORA3MAPTNPC1KMT2A | |
| SCHEMBL6269700 | 0.82 | ALDH1A1 (0.36) | MAPTKMT2AALDH1A1MEN1TSHR | |
| Hydrochloric Acid SCHEMBL8316265 | 0.81 | LMNA (0.40) | SMN1; SMN2ADORA3MAPTNPC1KMT2A | |
| SCHEMBL6268789 | 0.80 | HIF1A (0.36) | CACNA1CCACNA1FCACNA1DCACNA1SMAPT | |
| SCHEMBL8121742 | 0.80 | CTSL (0.37) | MAPTKMT2AALDH1A1MEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0995438-B1 | BENZOPYRAN DERIVATIVES FOR THE TREATMENT OF PERIPHERAL VASCULAR DISEASE | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2005-11-30 | — | — | EP | disclosed |
| US-6248777-B1 | VASCULAR DISORDERS | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2001-06-19 | — | — | US | disclosed |
| EP-0995438-A1 | REMEDIES FOR PERIPHERAL CIRCULATION DISTURBANCES | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2000-04-26 | — | — | EP | disclosed |
| EP-0702952-B1 | BENZOPYRAN DERIVATIVES | CHUGAI PHARMACEUTICAL CO LTD (JP) | 1999-12-08 | — | — | EP | disclosed |
| EP-0632033-B1 | NOVEL BENZOPYRAN DERIVATIVE | CHUGAI PHARMACEUTICAL CO LTD (JP) | 1999-04-07 | — | — | EP | disclosed |
| US-5646310-A | HYPOTENSIVE AGENTS, POTASSIUM CHANNEL ACTIVITY | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 1997-07-08 | — | — | US | disclosed |
| US-5646308-A | POTASSIUM CHANNEL ACTIVATORS USED AS ANTIASTHMATICS, ANTIEPILEPTICS | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 1997-07-08 | — | — | US | disclosed |
| EP-0702952-A1 | BENZOPYRAN DERIVATIVE | Chugai Seiyaku Kabushiki Kaisha (JP) | 1996-03-27 | — | — | EP | disclosed |
| EP-0632033-A1 | NOVEL BENZOPYRAN DERIVATIVE | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 1995-01-04 | — | — | EP | disclosed |